Tennessee 2025-2026 Regular Session

Tennessee Senate Bill SB1146 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2	<BillNo> <Sponsor>
3	3
4	4	SENATE BILL 1146
5	5	By Crowe
6	6
7	7
8	8	SB1146
9	9	002688
10	10	- 1 -
11	11
12	12	AN ACT to amend Tennessee Code Annotated, Title 38;
13	13	Title 53; Title 63 and Title 68, relative to
14	14	psychotropic drugs.
15	15
16	16	BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:
17	17	SECTION 1. Tennessee Code Annotated, Section 38-7-109, is amended by adding the
18	18	following as a new subsection:
19	19	(c)
20	20	(1)
21	21	(A) If a county medical examiner's office or regional forensic center is
22	22	conducting an autopsy on a decedent who is suspected to have committed a
23	23	mass shooting that resulted in the deaths of four (4) or more individuals, then the
24	24	county medical examiner or regional forensic center shall consult such
25	25	decedent's treating mental health professional or primary care physician, if
26	26	known and reasonably able to be identified through the decedent's next of kin, to
27	27	obtain information regarding the decedent's psychotropic drug use.
28	28	(B) The county medical examiner shall test the decedent for the
29	29	presence of any drugs, including psychotropic drugs.
30	30	(2)
31	31	(A) The county medical examiner's office or regional forensic center shall
32	32	disclose the drug use of the decedent to the University of Tennessee's health
33	33	science center and to the department of health.
34	34	(B) The county medical examiner's office or regional forensic center shall
35	35	not disclose any identifying information including the decedent's name or social
36	36
37	37
38	38	- 2 - 002688
39	39
40	40	security number when disclosing the drug use of the decedent to the University
41	41	of Tennessee's health science center and to the department of health.
42	42	(3) The University of Tennessee's health science center shall study the drug
43	43	interactions between the psychotropic drugs and any other drugs that were present in
44	44	the decedent's system as provided by the county medical examiner as described in
45	45	subdivision (c)(2)(A).
46	46	(4) The University of Tennessee's health science center shall submit quarterly
47	47	reports of all data obtained pursuant to this section to the chair of the health and welfare
48	48	committee of the senate and the chair of the house of representatives committee having
49	49	jurisdiction over health-related matters.
50	50	(5) As used in this subsection (c), "psychotropic drug" means a medication
51	51	prescribed for the treatment of mental or behavioral health conditions or a drug
52	52	prescribed for any condition that exercises a direct effect upon the central nervous
53	53	system and that is capable of influencing and modifying mood, perceptions, and
54	54	behavior, including:
55	55	(A) Agents for control of mania and depression;
56	56	(B) Antidepressants;
57	57	(C) Antipsychotics;
58	58	(D) Anxiolytics;
59	59	(E) Hypnotics;
60	60	(F) Mood stabilizers;
61	61	(G) Hormonal medication with the primary goal of altering a person's
62	62	physical appearance and sexual characteristics existing at the person's birth;
63	63	(H) Psychomotor stimulants; and
64	64	(I) Stimulants.
65	65
66	66
67	67	- 3 - 002688
68	68
69	69	(6) The county medical examiner, regional forensic center, department of health,
70	70	and the University of Tennessee's health science center must follow all relevant state
71	71	and federal privacy laws related to the implementation of this section.
72	72	SECTION 2. This act takes effect July 1, 2025, the public welfare requiring it.